Role of neutrophils in atherogenesis: an update

The role of neutrophils in the beginning and the progression of the atherosclerotic process did not receive much attention until the last years. On the contrary, recent data, in both the experimental animals and humans, suggest important effects of these cells with possible clinical consequences.

[1]  D. Cota,et al.  The Endocannabinoid System: Pivotal Orchestrator of Obesity and Metabolic Disease , 2015, Trends in Endocrinology & Metabolism.

[2]  G. Figtree,et al.  Redox biomarkers in cardiovascular medicine. , 2015, European heart journal.

[3]  Oliver Soehnlein,et al.  Atherosclerosis - A matter of unresolved inflammation. , 2015, Seminars in immunology.

[4]  G. Hansson,et al.  Anti-inflammatory therapies for atherosclerosis , 2015, Nature Reviews Cardiology.

[5]  K. Preissner,et al.  Coronary neutrophil extracellular trap burden and deoxyribonuclease activity in ST-elevation acute coronary syndrome are predictors of ST-segment resolution and infarct size. , 2015, Circulation research.

[6]  J. Michel,et al.  Thrombi and neutrophils. , 2015, Circulation research.

[7]  Joel T. Dudley,et al.  Genome-wide significant loci: how important are they? Systems genetics to understand heritability of coronary artery disease and other common complex disorders. , 2015, Journal of the American College of Cardiology.

[8]  A. Giatromanolaki,et al.  Expression of functional tissue factor by neutrophil extracellular traps in culprit artery of acute myocardial infarction , 2015, European heart journal.

[9]  Yuan-Lin Guo,et al.  Usefulness of the neutrophil-to-lymphocyte ratio in predicting the severity of coronary artery disease: a Gensini score assessment. , 2014, Journal of atherosclerosis and thrombosis.

[10]  U. Förstermann,et al.  Vascular oxidative stress, nitric oxide and atherosclerosis. , 2014, Atherosclerosis.

[11]  V. Hérias,et al.  CXCR4 blockade induces atherosclerosis by affecting neutrophil function. , 2014, Journal of molecular and cellular cardiology.

[12]  S. Pedersen,et al.  Plasma Neutrophil Gelatinase-Associated Lipocalinin in the General Population: Association With Inflammation and Prognosis , 2014, Arteriosclerosis, thrombosis, and vascular biology.

[13]  Paul M Ridker,et al.  Anti-inflammatory therapies for cardiovascular disease. , 2014, European heart journal.

[14]  Ira Tabas,et al.  Inflammation and its Resolution as Determinants of Acute Coronary Syndromes , 2014, Circulation research.

[15]  A. Zernecke,et al.  Chemokines in Atherosclerosis: Proceedings Resumed , 2014, Arteriosclerosis, thrombosis, and vascular biology.

[16]  P. Thompson,et al.  Peptidylarginine Deiminase Inhibition Reduces Vascular Damage and Modulates Innate Immune Responses in Murine Models of Atherosclerosis , 2014, Circulation research.

[17]  R. Witkamp,et al.  The endocannabinoid system: an emerging key player in inflammation , 2014, Current opinion in clinical nutrition and metabolic care.

[18]  F. Mach,et al.  Statin Treatment Is Associated with Reduction in Serum Levels of Receptor Activator of NF-κB Ligand and Neutrophil Activation in Patients with Severe Carotid Stenosis , 2014, Mediators of inflammation.

[19]  F. Mach,et al.  Update on selective treatments targeting neutrophilic inflammation in atherogenesis and atherothrombosis , 2013, Thrombosis and Haemostasis.

[20]  A. Ballestrero,et al.  Nicotinamide phosphoribosyltransferase inhibition reduces intraplaque CXCL1 production and associated neutrophil infiltration in atherosclerotic mice , 2013, Thrombosis and Haemostasis.

[21]  J. Vallée,et al.  Treatment with the CC chemokine-binding protein Evasin-4 improves post-infarction myocardial injury and survival in mice , 2013, Thrombosis and Haemostasis.

[22]  F. Miller,et al.  Inhibition of NADPH Oxidase by Apocynin Attenuates Progression of Atherosclerosis , 2013, International journal of molecular sciences.

[23]  P. Libby,et al.  Immune effector mechanisms implicated in atherosclerosis: from mice to humans. , 2013, Immunity.

[24]  F. Montecucco,et al.  Pathophysiological role of neutrophils in acute myocardial infarction , 2013, Thrombosis and Haemostasis.

[25]  A. Zarbock,et al.  Integrin Regulation during Leukocyte Recruitment , 2013, The Journal of Immunology.

[26]  F. Trotta,et al.  Polymorphonuclear neutrophils and instability of the atherosclerotic plaque: a causative role? , 2013, Inflammation Research.

[27]  T. V. van Berkel,et al.  Leukocyte-Specific CCL3 Deficiency Inhibits Atherosclerotic Lesion Development by Affecting Neutrophil Accumulation , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[28]  D. Wagner,et al.  Neutrophil extracellular traps , 2013, Oncoimmunology.

[29]  B. Cravatt,et al.  Fatty Acid Amide Hydrolase Deficiency Enhances Intraplaque Neutrophil Recruitment in Atherosclerotic Mice , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[30]  C. Combescure,et al.  Serum levels of anti-apolipoprotein A-1 auto-antibodies and myeloperoxidase as predictors of major adverse cardiovascular events after carotid endarterectomy , 2013, Thrombosis and Haemostasis.

[31]  M. Nahrendorf,et al.  Leukocyte Behavior in Atherosclerosis, Myocardial Infarction, and Heart Failure , 2013, Science.

[32]  S. Rajagopalan,et al.  Effects of a Novel Pharmacologic Inhibitor of Myeloperoxidase in a Mouse Atherosclerosis Model , 2012, PloS one.

[33]  J. Michel,et al.  From intraplaque haemorrhages to plaque vulnerability: biological consequences of intraplaque haemorrhages , 2012, Journal of cardiovascular medicine.

[34]  A. Zychlinsky,et al.  Neutrophil extracellular traps: Is immunity the second function of chromatin? , 2012, The Journal of cell biology.

[35]  K. Ley,et al.  Slings enable neutrophil rolling at high shear , 2012, Nature.

[36]  F. Montecucco,et al.  At the heart of the matter: the endocannabinoid system in cardiovascular function and dysfunction. , 2012, Trends in pharmacological sciences.

[37]  N. Stergiopulos,et al.  The activation of the cannabinoid receptor type 2 reduces neutrophilic protease-mediated vulnerability in atherosclerotic plaques. , 2012, European heart journal.

[38]  Oliver Soehnlein,et al.  Multiple roles for neutrophils in atherosclerosis. , 2012, Circulation research.

[39]  C. Weber,et al.  Presence of luminal neutrophil extracellular traps in atherosclerosis , 2012, Thrombosis and Haemostasis.

[40]  M. Reilly,et al.  Genetic Basis of Atherosclerosis: Insights From Mice and Humans , 2012, Circulation research.

[41]  O. Ratib,et al.  Receptor activator of NF-κB ligand (RANKL) increases the release of neutrophil products associated with coronary vulnerability , 2011, Thrombosis and Haemostasis.

[42]  E. Eriksson.  Intravital Microscopy on Atherosclerosis in Apolipoprotein E–Deficient Mice Establishes Microvessels as Major Entry Pathways for Leukocytes to Advanced Lesions , 2011, Circulation.

[43]  S. Galli,et al.  Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils , 2011, Nature Immunology.

[44]  M. Gianni,et al.  Neutrophils and clinical outcomes in patients with acute coronary syndromes and/or cardiac revascularisation , 2011, Thrombosis and Haemostasis.

[45]  Alberto Mantovani,et al.  Neutrophils in the activation and regulation of innate and adaptive immunity , 2011, Nature Reviews Immunology.

[46]  E. Boerwinkle,et al.  Relationship between circulating levels of RANTES (regulated on activation, normal T-cell expressed, and secreted) and carotid plaque characteristics: the Atherosclerosis Risk in Communities (ARIC) Carotid MRI Study. , 2011, European heart journal.

[47]  F. Mach,et al.  Anti-Apolipoprotein A-1 auto-antibodies are active mediators of atherosclerotic plaque vulnerability. , 2011, European heart journal.

[48]  Oliver Soehnlein,et al.  Hyperlipidemia-Triggered Neutrophilia Promotes Early Atherosclerosis , 2010, Circulation.

[49]  E. Falk,et al.  Atherosclerotic lesions in mouse and man: is it the same disease? , 2010, Current opinion in lipidology.

[50]  F. Moll,et al.  High Neutrophil Numbers in Human Carotid Atherosclerotic Plaques Are Associated With Characteristics of Rupture-Prone Lesions , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[51]  J. Hartwig,et al.  Extracellular DNA traps promote thrombosis , 2010, Proceedings of the National Academy of Sciences.

[52]  A. Gayet-Ageron,et al.  Systemic and Intraplaque Mediators of Inflammation Are Increased in Patients Symptomatic for Ischemic Stroke , 2010, Stroke.

[53]  A. Corsini,et al.  Role of polymorphonuclear neutrophils in atherosclerosis: current state and future perspectives. , 2010, Atherosclerosis.

[54]  C. Ledent,et al.  Activation of cannabinoid 2 receptors protects against cerebral ischemia by inhibiting neutrophil recruitment , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[55]  Zuyi Yuan,et al.  Activation of Cannabinoid CB2 Receptor Ameliorates Atherosclerosis Associated With Suppression of Adhesion Molecules , 2010, Journal of cardiovascular pharmacology.

[56]  Adelaide M. Arruda-Olson,et al.  Neutrophilia Predicts Death and Heart Failure After Myocardial Infarction: A Community-Based Study , 2009, Circulation. Cardiovascular quality and outcomes.

[57]  S. Rensen,et al.  Neutrophil Activation in Morbid Obesity, Chronic Activation of Acute Inflammation , 2009, Obesity.

[58]  V. Rudolph,et al.  Contribution of myeloperoxidase to smoking-dependent vascular inflammation. , 2008, Proceedings of the American Thoracic Society.

[59]  P. Libby,et al.  Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. , 2008, The New England journal of medicine.

[60]  S. Sela,et al.  Primed polymorphonuclear leukocytes constitute a possible link between inflammation and oxidative stress in hyperlipidemic patients. , 2008, Atherosclerosis.

[61]  P. Lavie,et al.  Delayed neutrophil apoptosis in patients with sleep apnea. , 2008, American journal of respiratory and critical care medicine.

[62]  F. Tacke,et al.  Protective Role of CXC Receptor 4/CXC Ligand 12 Unveils the Importance of Neutrophils in Atherosclerosis , 2008, Circulation research.

[63]  J. Michel,et al.  Involvement of intraplaque hemorrhage in atherothrombosis evolution via neutrophil protease enrichment , 2007, Journal of leukocyte biology.

[64]  P. Heeringa,et al.  Accumulation of Myeloperoxidase-Positive Neutrophils in Atherosclerotic Lesions in LDLR−/− Mice , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[65]  E. Dejana,et al.  The role of junctional adhesion molecules in vascular inflammation , 2007, Nature Reviews Immunology.

[66]  Stephen R. Clark,et al.  Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood , 2007, Nature Medicine.

[67]  Carl Nathan,et al.  Neutrophils and immunity: challenges and opportunities , 2006, Nature Reviews Immunology.

[68]  S. Sela,et al.  Primed peripheral polymorphonuclear leukocyte: a culprit underlying chronic low-grade inflammation and systemic oxidative stress in chronic kidney disease. , 2005, Journal of the American Society of Nephrology : JASN.

[69]  B. Coller.  Leukocytosis and Ischemic Vascular Disease Morbidity and Mortality: Is It Time to Intervene? , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[70]  J. Danesh,et al.  Associations between differential leucocyte count and incident coronary heart disease: 1764 incident cases from seven prospective studies of 30,374 individuals. , 2004, European heart journal.

[71]  S. Rankin,et al.  Chemokines acting via CXCR2 and CXCR4 control the release of neutrophils from the bone marrow and their return following senescence. , 2003, Immunity.

[72]  Kazuo Haze,et al.  Neutrophil Infiltration of Culprit Lesions in Acute Coronary Syndromes , 2002, Circulation.

[73]  S. Sela,et al.  Involvement of peripheral polymorphonuclear leukocytes in oxidative stress and inflammation in type 2 diabetic patients. , 2000, Diabetes care.

[74]  S. Sela,et al.  Participation of peripheral polymorphonuclear leukocytes in the oxidative stress and inflammation in patients with essential hypertension. , 1997, American journal of hypertension.

[75]  C. Weber,et al.  Modulation of Atherosclerotic Lesions by Circulating Cells : The Translational Spectrum , 2015 .

[76]  S. Sela,et al.  Involvement of Peripheral Polymorphonuclear Leukocytes in Oxidative Stress and Inflammation in Type 2 Diabetic Patients , 2001 .

[77]  Atherosclerotic Plaques , 1991, Nato ASI Series.